Poland says it won't take or pay for more COVID-19 vaccines for now

[April 19, 2022]  WARSAW (Reuters) - Poland won't take or pay for more doses of COVID-19 vaccine under the European Union's supply contract, its health minister said on Tuesday, setting the stage for a legal battle with manufacturers.

Poland, along with other EU members, has been receiving COVID-19 vaccines during the coronavirus pandemic under supply contracts agreed between the European Commission and vaccine makers such as BioNTech SE and Pfizer or Moderna.

Poland's biggest supplier is Pfizer. However, the country has seen lower vaccine uptake than most of the European Union and has surplus vaccine stock, part of which it has already sold or donated to other countries.

"At the end of last week, we used the force majeure clause and informed both the European Commission and the main vaccine producer that we are refusing to take these vaccines at the moment and we are also refusing to pay," health minister Adam Niedzielski told private broadcaster TVN24.

"Indeed, the consequence of this will be a legal conflict, which is already taking place," he said.

Poland cannot directly terminate the contract for the supply of vaccines as the parties to the contracts are the European Commission and manufacturers, he said.
 

A doctor prepares the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at the University Hospital in Bialystok, Poland January 4, 2021. Agnieszka Sadowska/Agencja Gazeta via REUTERS

The value of the contract for vaccine supplies to Poland up to the end of 2023 with one producer alone was worth over 6 billion zlotys ($1.40 billion), with over 2 billion zlotys of that for supply in 2022.

In Poland 59% of the population has been vaccinated with two doses and 31% has received a booster shot. This is well below the EU average of 72.5% and nearly 53%, respectively.

($1 = 4.2868 zlotys)

(Reporting by Alan Charlish and Anna Wlodarczak-Semczuk; Editing by Susan Fenton)
 

[© 2022 Thomson Reuters. All rights reserved.]  This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.